MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-HR-13-0008366
Habitare Pharma Private Limited
Habitare Pharma Private Limited - pharma in Barwala, Haryana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹12.79 Cr
▲ 17% YoY
Net profit · FY 2025
₹27.19 Lakh
Net margin 2.1%
EBITDA · FY 2025
₹72.36 Lakh
EBITDA margin 5.7%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered
About Habitare Pharma Private Limited
Data last updated:
Habitare Pharma Private Limited is a private limited company based in Barwala, Haryana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 October 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24304HR2019PTC083020. Its GSTIN is 06AAFCH0707B1ZA (Haryana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Kusum Lata and Madhur Pathak.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot/Shed No. 44 Hsiidc Industrial Estate Alipur, Barwala, Haryana, India – 134103.
As per the financials filed for FY 2025, the company reported a revenue of ₹12.79 Cr, a growth of 17% compared to the previous year. For the same year it recorded a net profit of ₹27.19 Lakh (net margin 2.1%) and EBITDA of ₹72.36 Lakh (EBITDA margin 5.7%). Revenue has grown at a compounded annual rate (CAGR) of 92% over three years and 74% over five years.
Court records list 97 cases involving the company, including 51 filed by the company and 46 filed against it; 40 cases are pending.
Habitare Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-13-0008366).
Company details
CIN U24304HR2019PTC083020
Registration Number 083020
Incorporation Date 14 October 2019
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
MSME Classification Small
Udyam Registration UDYAM-HR-13-0008366
Recognitions & Rankings of Habitare Pharma
Contact details
Habitare Pharma Private Limited's registered office is in Barwala, Haryana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot/Shed No. 44 Hsiidc Industrial Estate Alipur, Barwala, Haryana, India – 134103
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Habitare Pharma Private Limited, buy the company report.
Comprehensive company report
Habitare Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Habitare Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Habitare Pharma Private Limited, buy the company report.
Financials of Habitare Pharma Private Limited
FY 2024 filings availableHabitare Pharma Private Limited reported revenue of ₹12.79 Cr (up 17% YoY) for FY 2025.
Revenue · FY 2025
₹12.79 Cr ▲ 17%
Net profit · FY 2025
₹27.19 Lakh margin 2.1%
EBITDA · FY 2025
₹72.36 Lakh margin 5.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 17%
3 years · compounded
▲ 92%
5 years · compounded
▲ 74%
EBITDA CAGR growth
1 year
▲ 44%
3 years · compounded
▲ 82%
5 years · compounded
▲ 96%
Revenue has grown at a compounded annual rate (CAGR) of 74% over five years, including 17% growth in the latest year. EBITDA rose 44% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹72.36 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹27.19 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.7% | ||||
| Net Profit Margin | 2.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Habitare Pharma Private Limited, buy the company report.
Board of directors of Habitare Pharma Private Limited
Habitare Pharma has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kusum Lata | Director | 14 Oct 2019 | 7 Years 0 Months | Current |
| Madhur Pathak | Director | 14 Oct 2019 | 7 Years 0 Months | Current |
| Gopal Krishan Pathak | Director | 14 Oct 2019 | 7 Years 0 Months | Current |
Peer comparison
Habitare Pharma Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Recurso Wellness Private Limited | ₹12.82 Cr (FY 2023) | 159.0% | Ahmedabad, Gujarat, India | |||
| Apco Pharma Limited | ₹12.8 Cr (FY 2024) | 14.0% | New Delhi, Delhi, India | |||
| Salubrity Biotech Limited | ₹12.8 Cr (FY 2025) | 2.0% | Kolkata, West Bengal, India | |||
| Habitare Pharma Private Limitedthis company | ₹12.79 Cr (FY 2025) | ₹27.19 Lakh | 2.1% | 17.0% | Barwala, Haryana, India | |
| Thaiger Pharma Private Limited | ₹12.77 Cr (FY 2025) | -15.0% | Mumbai, Maharashtra, India | |||
| Soft Touch Pharmaceutical India Limited | ₹12.75 Cr (FY 2025) | 14.0% | Solan, Himachal Pradesh, India | |||
| Shalman Pharmaceuticals Private Limited | ₹12.73 Cr (FY 2024) | -3.0% | Vadodara, Gujarat, India | |||
| Reallab Biotech Private Limited | ₹12.68 Cr (FY 2025) | 23.0% | Meerut, Uttar Pradesh, India |
To see the full peer comparison of Habitare Pharma Private Limited, buy the company report.
Auditor
Habitare Pharma Private Limited is audited by ATUL SANGEETA & CO. for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ATUL SANGEETA & CO. | FY 2024 | 016183N |
Shareholding
The shareholding of Habitare Pharma Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Habitare Pharma Private Limited, buy the company report.
Legal cases
Habitare Pharma Private Limited has 97 court cases on record: 51 filed by Habitare Pharma, 46 filed against it. 40 cases are pending and 57 are disposed.
Total cases
97
Filed by the company
51
Filed against the company
46
Pending
40
Disposed
57
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 95 | 44 | 38 |
| High courts | 2 | 2 | 2 |
Cases on record (5 of 97)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ambala, Haryana | Cheque dishonour complaint | Filed against the company by HDFC Bank | Pending |
| District court, Solan, Himachal Pradesh | Cheque dishonour complaint | Filed against the company by M/S Sanchem Sophin Pvt Ltd. | Pending |
| District court, Central, Delhi | Cheque dishonour complaint | Filed against the company by Samchem India Private Limited | Pending |
| District court, Ambala, Haryana | Cheque dishonour complaint | Filed against the company by M/S M.K. Pharma Pvt Ltd | Pending |
| District court, South East, Delhi | Cheque dishonour complaint | Filed against the company by Rohan Pharma Pvt. Ltd. | Pending |
To see the full case history of Habitare Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Habitare Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Habitare Pharma Private Limited has 1 active EPFO establishment as of Mar 10, 2025.
Active EPFO establishments
1
GST
Habitare Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAFCH0707B1ZA | Haryana | Active | 28 Nov 2019 |
To see the full GST registrations and return filing status of Habitare Pharma Private Limited, buy the company report.
Recent activity
Habitare Pharma Private Limited has 3 board changes on record since 2019: 3 appointments. The latest: Gopal Krishan Pathak was appointed as Director on 14 Oct 2019.
AGM
Habitare Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Habitare Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Appointed
Gopal Krishan Pathak was appointed as Director.
Appointed
Kusum Lata was appointed as Director.
Appointed
Madhur Pathak was appointed as Director.
Incorporation
14 Oct 2019
Habitare Pharma Private Limited was registered on 14 Oct 2019 with Roc Delhi & aged 7 years 13 days as per MCA records.
Frequently asked questions
Habitare Pharma is an active private limited company based in Barwala, Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 14 October 2019 (7+ years old) and is registered under CIN U24304HR2019PTC083020.
Habitare Pharma has 3 current directors:
- Kusum Lata - Director
- Madhur Pathak - Director
- Gopal Krishan Pathak - Director
The latest financial statements of Habitare Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Habitare Pharma is 06AAFCH0707B1ZA, registered in Haryana.
The CIN (Corporate Identification Number) of Habitare Pharma is U24304HR2019PTC083020. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Habitare Pharma has 97 court cases on record: 51 filed by the company and 46 filed against it. 40 are pending. Most are in the district courts.
Habitare Pharma was incorporated on 14 October 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Habitare Pharma by revenue are Recurso Wellness Private Limited, Apco Pharma Limited, Salubrity Biotech Limited, Thaiger Pharma Private Limited, Soft Touch Pharmaceutical India Limited and 2 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Gopal Krishan Pathak was appointed as Director on 14 Oct 2019. Kusum Lata was appointed as Director on 14 Oct 2019. Madhur Pathak was appointed as Director on 14 Oct 2019.
Yes, Habitare Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-HR-13-0008366).
The registered office of Habitare Pharma is at PlotShed No. 44 Hsiidc Industrial Estate Alipur, Barwala, Haryana, India – 134103.